Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by KALSHEKER, N.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KALSHEKER, N.A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 1994; 87: 653-658
© 1994 Association of Physicians

review-article

Molecular pathology of {alpha}1-antitrypsin deficiency and its significance to clinical medicine

N.A. KALSHEKER

From the Department of Clinical Chemistry, University Hospital Nottingham, UK

Address correspondence to Professor N.A. Kalsheker, Department of Clinical Chemistry, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH

{alpha}1 -Antitrypsin (AAT) deficiency is associated with predisposition to developing liver cirrhosis in early childhood, and chronic degenerative lung disease in early adult life. The probable molecular basis for the disease associations is known. One of the common variants, Z, has the propensity to form polymers, a phenomenon which is concentration and temperature-dependent. This results in accumulation of the protein in hepatocytes, the predominant tissue source of AAT, and leads to cell damage. AAT deficiency results in loss of protection in the lung against neutrophil elastase (NE) the major target for AAT. NE is capable of destroying the architecture of the lung, leading to pulmonary emphysema. The disease process is exacerbated by cigarette smoke, which is capable of oxidizing a critical methionine residue at the active site, rendering AAT an inefficient inhibitor of NE. The combination of deficiency and cigarette smoking are critical to the development of pulmonary emphysema. We have identified a mutation in an enhancer sequence which, in all probability, predisposes to disease by a novel mechanism related to diminished expression of AAT during inflammation. Our understanding of the mechanisms of disease should lead to improved therapeutic interventions.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur J Heart FailHome page
C. Banfi, M. Brioschi, S. Barcella, F. Veglia, P. Biglioli, E. Tremoli, and P. Agostoni
Oxidized proteins in plasma of patients with heart failure: Role in endothelial damage
Eur J Heart Fail, March 1, 2008; 10(3): 244 - 251.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. M.v. Leeuwen, E. v. Agen, R. W.H. Gottschalk, R. Vlietinck, M. Gielen, M. H.M.v. Herwijnen, L. M. Maas, J. C.S. Kleinjans, and J. H.M.v. Delft
Cigarette smoke-induced differential gene expression in blood cells from monozygotic twin pairs
Carcinogenesis, March 1, 2007; 28(3): 691 - 697.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.